Evidence map›Paper›PMID 32934267›Full record

ArticleScientific reports2020

Structure-based inhibitors targeting the alpha-helical domain of the Spiroplasma melliferum histone-like HU protein.

Yuliya K Agapova, Dmitry A Altukhov, Vladimir I Timofeev, Victor S Stroylov, Vitaly S Mityanov, Dmitry A Korzhenevskiy, Anna V Vlaskina, Eugenia V Smirnova, Eduard V Bocharov, Tatiana V Rakitina

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Acetylation at Lysine 86 ofFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yuliya K Agapova *National Research Center "Kurchatov Institute", Akad. Kurchatova pl., 1, Moscow, 123182, Russian Federation. agapova.jk@gmil.com.
Dmitry A Altukhov *National Research Center "Kurchatov Institute", Akad. Kurchatova pl., 1, Moscow, 123182, Russian Federation.
Vladimir I TimofeevFederal Scientific Research Center "Crystallography and Photonics", Russian Academy of Sciences, Leninskii Pr., 59, Moscow, 119333, Russian Federation.
Victor S StroylovN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninskii pr., 47, Moscow, 119991, Russian Federation.
Vitaly S MityanovN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninskii pr., 47, Moscow, 119991, Russian Federation.
Dmitry A KorzhenevskiyNational Research Center "Kurchatov Institute", Akad. Kurchatova pl., 1, Moscow, 123182, Russian Federation.
Anna V VlaskinaNational Research Center "Kurchatov Institute", Akad. Kurchatova pl., 1, Moscow, 123182, Russian Federation.
Eugenia V SmirnovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, Moscow, 117997, Russian Federation.
Eduard V BocharovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, Moscow, 117997, Russian Federation. bon@nmr.ru.
Tatiana V RakitinaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, Moscow, 117997, Russian Federation. taniarakitina@yahoo.com.
Kurchatov Institute · RUInstitute of Bioorganic Chemistry · RUN.D. Zelinsky Institute of Organic Chemistry · RUFederal Scientific Research Centre Crystallography and Photonics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we report bisphenol derivatives of fluorene (BDFs) as a new type of chemical probes targeting a histone-like HU protein, a global regulator of bacterial nucleoids, via its dimerization interface perturbation. BDFs were identified by virtual screening and molecular docking that targeted the core of DNA-binding β-saddle-like domain of the HU protein from Spiroplasma melliferum. However, NMR spectroscopy, complemented with molecular dynamics and site-directed mutagenesis, indicated that the actual site of the inhibitors' intervention consists of residues from the α-helical domain of one monomer and the side portion of the DNA-binding domain of another monomer. BDFs inhibited DNA-binding properties of HU proteins from mycoplasmas S. melliferum, Mycoplasma gallicepticum and Escherichia coli with half-maximum inhibitory concentrations in the range between 5 and 10 µM. In addition, BDFs demonstrated antimicrobial activity against mycoplasma species, but not against E. coli, which is consistent with the compensatory role of other nucleoid-associated proteins in the higher bacteria. Further evaluation of antimicrobial effects of BDFs against various bacteria and viruses will reveal their pharmacological potential, and the allosteric inhibition mode reported here, which avoids direct competition for the binding site with DNA, should be considered in the development of small molecule inhibitors of nucleoid-associated proteins as well as other types of DNA-binding multimeric proteins.

Indexed as

Molecular Docking SimulationProtein Conformation, alpha-HelicalAmino Acid SequenceBacterial ProteinsBinding SitesDNA, BacterialDNA-Binding ProteinsFluorenesHigh-Throughput Screening AssaysHistonesMolecular Dynamics SimulationSpiroplasmaBacterial ProteinsDNA, BacterialDNA-Binding ProteinsFluoreneshistone-like protein HU, bacteriaHistones

Identifiers

PMID32934267
PMCPMC7493962
OpenAlexW3087492904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.